Coronavirus Diagnostics Market Increasing Demand With Leading Players- Beckman Coulter, QIAGEN, Hologic
Research Reports
Jan 13, 2021
Latest Report Available at Advance Market Analytics, “Coronavirus Diagnostics Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The global Coronavirus Diagnostics market focuses on encompassing major statistical evidence for the Coronavirus Diagnostics industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Coronavirus Diagnostics study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.
Key players in the global Coronavirus Diagnostics market
F. Hoffmann-La Roche AG (Switzerland), Bio-Rad Laboratories Inc. (United States), Beckman Coulter Inc. (United States), Becton, Dickinson, and Company (United States), Lonza Group AG (Switzerland), Hologic, Inc. (United States), QIAGEN (Germany), GlaxoSmithKline Biologicals SA (Belgium), Abbott Laboratories (United States), Perkin Elmer, Inc. (United States), Neuberg Diagnostics (India), 1drop Inc. (Switzerland), Veredus Laboratories (Hong Kong), ADT Biotech (Malaysia), Quest Diagnostics (United States), LabCorp (United States), altona Diagnostics GmbH (Germany), bioMérieux SA (France) and Mylab Discovery Solutions Pvt Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aldatu Biosciences (United States), Quidel Corporation (United States), Luminex Corporation (United States) and Cepheid Inc. (United States).
Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/129953-global-coronavirus-diagnostics-market
Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 represents the virus’s membership of the coronavirus family, with its first human interaction noted in 2019. Coronavirus is the term coined for the family of viruses that are transmitted between animals and humans. Hence they are also known as zoonotic viruses. In addition, the virus outbreak was confirmed on March 27, 2020, on six continents and in more than 197 countries. According to the World Health Organization (WHO), fever, fatigue and dry cough are common symptoms of Covid-19 infection. Other symptoms of the disease include shortness of breath, sore throat, pain, and diarrhea in some cases, as well as nausea or a runny nose. In addition, this infection can spread from one person to another through droplets of saliva, or it can leak out of the nose when an infected person coughs or sneezes. The time from a person’s exposure to Covid-19 to the onset of symptoms is generally between two and fourteen days, with an average of five days. The current status of lead COVID testing is toward increasing capacity but mixed accuracy. For efficient and accurate COVID-19 diagnosis, doctors need a portable or on-site diagnostic test to be able to manage patients in real-time in the shortest possible time. This has encouraged the introduction of point-of-care (POC) tests for diagnosis, the primary aim of which is to cut test times from hours to minutes. The most common concern of the governments of all nations affected by Covid-19 is the intolerable need to screen and test large numbers of patients for possible Sars-Cov-2 infections. As a result, most of them face significant bottlenecks in the supply of diagnostic kits to test for the virus. Diagnostic virology companies have been under immense pressure so as to provide reliable test kits and also the demand for the in vitro or point-of-care testing capabilities in the laboratories in various countries is also increasing. However, with the introduction of automated SARS-CoV-2 test systems, the diagnosis increases its capacity to carry out such tests considerably. However, currently, only a few companies are focused on developing rapid immunoassay tests for Covid-19 diagnosis.
Influencing Market Trend
- A Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing
- An Upsurge in Validating and Developing Rapid POC Immunodiagnostic Tests to Facilitate Decentralized Testing
- Growing Trend of Incorporation of Artificial Intelligence (AI) in the COVID-19 Tests for Rapid and Efficient Diagnosis
Market Drivers
- The Increasing Global Prevalence of COVID-19
- Unavailability of Specific Medicine or a Vaccine for the Coronavirus Disease
- An Increase in the Need for Developing Diagnostic Tests Owing to the Global Conditions
- The Increased Demand for Rapid Immunoassay Tests for Disease Diagnosis
Opportunities
- Growth in Funding For Research on Coronavirus Diagnostics
- Increasing Application of Molecular Diagnostic Technologies in Pharmacogenetics and Point-Of-Care Testing
- The Rise in Integration of Novel Technologies and Software Solutions with COVID-19 Testing
Restraints
- Lack of Awareness among Developing Countries Regarding the Necessary Precautions to Be Taken
Challenges
- Shortage of Medical Professionals That Have Sufficient Knowledge Regarding the Use of Diagnostic Kits for COVID-19
Download PDF Sample of Coronavirus Diagnostics Market report @ https://www.advancemarketanalytics.com/download-report/129953-global-coronavirus-diagnostics-market
The Global Coronavirus Diagnostics Market segments and Market Data Break Down are illuminated below:
by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV), End-Users (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Diagnostic Centers and Clinics, Research Institutes, Others), Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab), Mode of Diagnosis (Point-of-Care (POC), Non-Point-of-Care (Non-PoC))
The Coronavirus Diagnostics market study further highlights the segmentation of the Coronavirus Diagnostics industry on a global distribution. The report focuses on regions of LATAM, North America, Europe, Asia, and the Rest of the World in terms of developing market trends, preferred marketing channels, investment feasibility, long term investments, and business environmental analysis. The Coronavirus Diagnostics report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.
In addition, the Coronavirus Diagnostics market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Coronavirus Diagnostics market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.
The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Coronavirus Diagnostics industry as it explores the competitive nature of the market complete with a regional analysis.
Brief about Coronavirus Diagnostics Market Report with TOC @ https://www.advancemarketanalytics.com/reports/129953-global-coronavirus-diagnostics-market
Some Point of Table of Content:
Chapter One: Report Overview
Chapter Two: Global Market Growth Trends
Chapter Three: Value Chain of Coronavirus Diagnostics Market
Chapter Four: Players Profiles
Chapter Five: Global Coronavirus Diagnostics Market Analysis by Regions
Chapter Six: North America Coronavirus Diagnostics Market Analysis by Countries
Chapter Seven: Europe Coronavirus Diagnostics Market Analysis by Countries
Chapter Eight: Asia-Pacific Coronavirus Diagnostics Market Analysis by Countries
Chapter Nine: Middle East and Africa Coronavirus Diagnostics Market Analysis by Countries
Chapter Ten: South America Coronavirus Diagnostics Market Analysis by Countries
Chapter Eleven: Global Coronavirus Diagnostics Market Segment by Types
Chapter Twelve: Global Coronavirus Diagnostics Market Segment by Applications
Buy the Latest Detailed Report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=129953
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, West Europe or Southeast Asia.
About Author:
Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies’ revenues.
Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English